CIK 0001439222 · Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-05-31 | MARAGANORE JOHN Director | Grant or award · Restricted stock units | +1,400 | 1,400 | ||
| 2018-05-31 | Ho Maykin Director | Grant or award · Stock option (right to buy) | +5,700 | 5,700 | ||
| 2018-05-31 | Ho Maykin Director | Grant or award · Restricted stock units | +1,400 | 1,400 | ||
| 2018-05-31 | FOUSE JACQUALYN A Director | Grant or award · Stock option (right to buy) | +5,700 | 5,700 | ||
| 2018-05-31 | FOUSE JACQUALYN A Director | Grant or award · Restricted stock units | +1,400 | 1,400 | ||
| 2018-05-31 | Foster-Cheek Kaye I Director | Grant or award · Stock option (right to buy) | +5,700 | 5,700 | ||
| 2018-05-31 | Foster-Cheek Kaye I Director | Grant or award · Restricted stock units | +1,400 | 1,400 | ||
| 2018-05-31 | CLARK IAN T Director | Grant or award · Stock option (right to buy) | +5,700 | 5,700 | ||
| 2018-05-31 | CLARK IAN T Director | Grant or award · Restricted stock units | +1,400 | 1,400 | ||
| 2018-05-31 | Clancy Paul J Director | Grant or award · Stock option (right to buy) | +5,700 | 5,700 | ||
| 2018-05-31 | Clancy Paul J Director | Grant or award · Restricted stock units | +1,400 | 1,400 | ||
| 2018-05-30 | Schenkein David P Chief Executive Officer | Option exercise | +5,962 | $0.30 | $2K | 5,962 |
| 2018-05-30 | Schenkein David P Chief Executive Officer | Option exercise | +16,193 | $0.30 | $5K | 22,155 |
| 2018-05-30 | Schenkein David P Chief Executive Officer | Option exercise | +23,471 | $0.47 | $11K | 45,626 |
| 2018-05-30 | Schenkein David P Chief Executive Officer | Sale | −45,626 | $90.07 | $4.1M | 0 |
| 2018-05-30 | Schenkein David P Chief Executive Officer | Option exercise · Stock option (right to buy) | −5,962 | 0 | ||
| 2018-05-30 | Schenkein David P Chief Executive Officer | Option exercise · Stock option (right to buy) | −16,193 | 0 | ||
| 2018-05-30 | Schenkein David P Chief Executive Officer | Option exercise · Stock option (right to buy) | −23,471 | 12,892 | ||
| 2018-05-23 | Biller Scott Chief Scientific Officer | Option exercise · Stock option (right to buy) | −15,177 | 14,862 | ||
| 2018-05-23 | Schenkein David P Chief Executive Officer | Option exercise | +49,374 | $0.30 | $15K | 49,374 |
Page 61 of 63 · 1,252 trades